X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8) 8
oncology (7) 7
female (6) 6
humans (6) 6
male (6) 6
care and treatment (5) 5
chemotherapy (5) 5
lung cancer, non-small cell (5) 5
mutation (5) 5
aged (4) 4
cancer (4) 4
middle aged (4) 4
research (4) 4
adult (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
lung cancer (3) 3
prospective studies (3) 3
respiratory system (3) 3
survival (3) 3
survival analysis (3) 3
tumors (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
bacteria (2) 2
cancer patients (2) 2
carboplatin (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
carcinoma, non-small-cell lung - pathology (2) 2
carcinoma, non-small-cell lung - therapy (2) 2
cisplatin (2) 2
cisplatin - administration & dosage (2) 2
clinical trials (2) 2
colorectal cancer (2) 2
concurrent chemoradiotherapy (2) 2
congenital, hereditary, and neonatal diseases and abnormalities (2) 2
critical care medicine (2) 2
disease-free survival (2) 2
docetaxel (2) 2
epidermal growth factor receptors (2) 2
erlotinib (2) 2
exons (2) 2
gefitinib (2) 2
gemcitabine (2) 2
gene mutations (2) 2
genetic aspects (2) 2
genetic screening (2) 2
germline mutations (2) 2
health aspects (2) 2
hematology, oncology and palliative medicine (2) 2
immunotherapy (2) 2
intravenous administration (2) 2
latin america (2) 2
latin america - epidemiology (2) 2
lung neoplasms - drug therapy (2) 2
lung neoplasms - genetics (2) 2
lung neoplasms - pathology (2) 2
lung neoplasms - therapy (2) 2
lynch syndrome (2) 2
management (2) 2
mmr (2) 2
mortality (2) 2
msh2 mutations (2) 2
neoplasms. tumors. oncology. including cancer and carcinogens (2) 2
non-small cell lung carcinoma (2) 2
nonpolyposis colorectal-cancer (2) 2
open-label (2) 2
patients (2) 2
platinum (2) 2
pulmonary/respiratory (2) 2
radiation (2) 2
randomized controlled-trial (2) 2
risk (2) 2
studies (2) 2
toxicity (2) 2
treatment outcome (2) 2
1st-line therapy (1) 1
acids (1) 1
acoustic differentiation (1) 1
acquired-resistance (1) 1
adjuvants (1) 1
administration, oral (1) 1
aged, 80 and over (1) 1
agriculture (1) 1
aids/hiv (1) 1
alcohol (1) 1
analysis (1) 1
anemia (1) 1
antibacterial coatings (1) 1
antiinfectives and antibacterials (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antiretroviral therapy (1) 1
antitubercular agents - therapeutic use (1) 1
apoptosis (1) 1
artikkel (1) 1
aspartate aminotransferase (1) 1
atezolizumab (1) 1
bevacizumab - administration & dosage (1) 1
biofilms (1) 1
biomedical materials (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Rosell, Rafael, Dr and Carcereny, Enric, MD and Gervais, Radj, MD and Vergnenegre, Alain, Prof and Massuti, Bartomeu, MD and Felip, Enriqueta, MD and Palmero, Ramon, MD and Garcia-Gomez, Ramon, MD and Pallares, Cinta, MD and Sanchez, Jose Miguel, MD and Porta, Rut, MD and Cobo, Manuel, MD and Garrido, Pilar, MD and Longo, Flavia, MD and Moran, Teresa, MD and Insa, Amelia, MD and De Marinis, Filippo, MD and Corre, Romain, MD and Bover, Isabel, MD and Illiano, Alfonso, MD and Dansin, Eric, MD and de Castro, Javier, MD and Milella, Michele, MD and Reguart, Noemi, MD and Altavilla, Giuseppe, MD and Jimenez, Ulpiano, MD and Provencio, Mariano, MD and Moreno, Miguel Angel, MD and Terrasa, Josefa, MD and Muñoz-Langa, Jose, MD and Valdivia, Javier, MD and Isla, Dolores, MD and Domine, Manuel, MD and Molinier, Olivier, MD and Mazieres, Julien, Prof and Baize, Nathalie, MD and Garcia-Campelo, Rosario, MD and Robinet, Gilles, MD and Rodriguez-Abreu, Delvys, MD and Lopez-Vivanco, Guillermo, MD and Gebbia, Vittorio, MD and Ferrera-Delgado, Lioba, MD and Bombaron, Pierre, MD and Bernabe, Reyes, MD and Bearz, Alessandra, MD and Artal, Angel, MD and Cortesi, Enrico, MD and Rolfo, Christian, MD and Sanchez-Ronco, Maria, PhD and Drozdowskyj, Ana, PhD and Queralt, Cristina, PhD and de Aguirre, Itziar, PhD and Ramirez, Jose Luis, PhD and Sanchez, Jose Javier, Prof and Molina, Miguel Angel, PhD and Taron, Miquel, PhD and Paz-Ares, Luis, MD and Assoc Italiana Oncologia Toracica and Grp Francais Pneumocancerologie and Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 239 - 246
Summary Background Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line treatment for Asian... 
Hematology, Oncology and Palliative Medicine | IPASS | GEFITINIB | THERAPY | ONCOLOGY | SENSITIVITY | CARBOPLATIN/PACLITAXEL | TUMORS | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Exons | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Cisplatin - administration & dosage | Patient Selection | Time Factors | Female | Quinazolines - administration & dosage | Precision Medicine | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Erlotinib | Lung cancer | Product development | Agriculture | Lung cancer, Non-small cell | Antineoplastic agents | Standards | Cancer
Journal Article
Lancet Respiratory Medicine, The, ISSN 2213-2600, 2017, Volume 5, Issue 5, pp. 435 - 444
Journal Article
BMC CANCER, ISSN 1471-2407, 02/2019, Volume 19, Issue 1, pp. 165 - 9
BackgroundDiabetes is related with increased cancer mortality across multiple cancer types. Its role in lung cancer mortality is still unclear. We aim to... 
DIABETES-MELLITUS | MORTALITY | Hyperglycemia | IMPACT | Comorbidities | ONCOLOGY | Locally advanced unresectable non-small cell lung cancer | Concurrent chemoradiotherapy | RISK | Type 2 diabetes mellitus
Journal Article
The Lancet Respiratory Medicine, ISSN 2213-2600, 10/2018, Volume 6, Issue 10, pp. 771 - 781
Anti-programmed death-1 (PD-1) treatment for advanced non-small-cell lung cancer (NSCLC) has improved the survival of patients. However, a substantial... 
HUMAN GENOME | IMMUNOTHERAPY | RESPIRATORY SYSTEM | CPG SITES | ACQUIRED-RESISTANCE | CD4(+) T-CELLS | OPEN-LABEL | RANDOMIZED CONTROLLED-TRIAL | DOCETAXEL | DNA METHYLATION MICROARRAY | TUMOR-IMMUNITY | CRITICAL CARE MEDICINE | Cancer patients | Research | Lung cancer, Non-small cell | Drug therapy | Health aspects | Immune system
Journal Article
by Garassino, Marina Chiara and Cho, Byoung-Chul and Kim, Dong-Wan and Kim, Joo-Hang and Kim, Sang-We and Kim, Young-Chul and Mazières, Julien and Vansteenkiste, Johan and Lena, Hervé and Corral Jaime, Jesus and Gray, Jhanelle E and Powderly, John and Chouaid, Christos and Bidoli, Paolo and Wheatley-Price, Paul and Park, Keunchil and Soo, Ross A and Huang, Yifan and Wadsworth, Catherine and Dennis, Phillip A and Rizvi, Naiyer A and Paz-Ares Rodriguez, Luis and Novello, Silvia and Hiret, Sandrine and Schmid, Peter and Laack, Eckart and Califano, Raffaele and Maemondo, Makoto and Chaft, Jamie and Vicente Baz, David and Berghmans, Thierry and Surmont, Veerle and Reck, Martin and Han, Ji-Youn and Holgado Martin, Esther and Belda Iniesta, Cristobal and Oe, Yuichiro and Chella, Antonio and Chopra, Akhil and Robinet, Gilles and Soto Parra, Hector and Thomas, Michael and Cheema, Parneet and Katakami, Nobuyuki and Su, Wu-Chou and Wolf, Juergen and Lee, Jong-Seok and Saka, Hideo and Milella, Michele and Ramos Garcia, Inmaculada and Sibille, Anne and Yokoi, Takashi and Kang, Eun Joo and Atagi, Shinji and Spaeth-Schwalbe, Ernst and Nishio, Makoto and Imamura, Fumio and Gabrail, Nashat and Veillon, Remi and Derijcke, Sofie and Maeda, Tadashi and Zylla, Dylan and Kubiak, Kendra and Santoro, Armando and Uy, Ma. Noemi and Lucien Geater, Sarayut and Italiano, Antoine and Kowalski, Dariusz and Barlesi, Fabrice and Chen, Yuh-Min and Spigel, David and Chewaskulyong, Busyamas and Garcia Gomez, Ramon and Alvarez Alvarez, Rosa and Yang, Chih-Hsin and Hsia, Te-Chun and Denis, Fabrice and Sakai, Hiroshi and Vincent, Mark and Goto, Koichi and Bosch-Barrera, Joaquim and Weiss, Glen and Canon, Jean-Luc and Scholz, Christian and Aglietta, Massimo and Kemmotsu, Hirotsugu and Azuma, Koichi and Bradbury, Penelope and Feld, Ronald and Chachoua, Abraham and Jassem, Jacek and Juergens, Rosalyn and Palmero Sanchez, Ramon and Malcolm, Albert and Vrindavanam, Nandagopal and Kubota, Kaoru and Waller, Cornelius and Waterhouse, David and Coudert, Bruno and Mark, Zsuzsanna and ... and ATLANTIC Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 521 - 536
Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC) without tyrosine kinase or anaplastic... 
MULTICENTER | METAANALYSIS | NSCLC | ONCOLOGY | RANDOMIZED CONTROLLED-TRIAL | ATEZOLIZUMAB | IMMUNE CHECKPOINT | NIVOLUMAB | MEDI4736 | CLINICAL ACTIVITY | DOCETAXEL | Lung cancer, Non-small cell | Care and treatment
Journal Article
British Journal of Cancer, ISSN 0007-0920, 03/2018, Volume 118, Issue 5, pp. 639 - 647
Journal Article
Lung Cancer, ISSN 0169-5002, 2011, Volume 74, Issue 1, pp. 69 - 74
Journal Article
BMC Cancer, ISSN 1471-2407, 09/2017, Volume 17, Issue 1, pp. 623 - 26
Journal Article
Journal Article
Bioacoustics, ISSN 0952-4622, 10/2012, Volume 21, Issue 3, pp. 175 - 191
The spectacled warbler (Sylvia conspicillata) is a small passerine with a patchy distribution throughout the circum-Mediterranean region, including the North... 
complex song | acoustic differentiation | song characterization | Fuerteventura | repertoire size | Sylvia conspicillata | Acoustic differentiation | Song characterization | Repertoire size | Complex song | STONECHAT SAXICOLA-DACOTIAE | DARWINS FINCHES | MATE RECOGNITION | SEXUAL SELECTION | BIRD SONG | ZEBRA FINCH | PARUS-MAJOR | EVOLUTION | ZOOLOGY | FEMALE GREAT TITS
Journal Article